A $27.9K sale of 435 shares is proposed by PTC Therapeutics (PTCT) officer Mark Boulding. - Stock Titan

Source: Stock Titan · 2026-10-06T20:07:56+00:00

A $27.9K sale of 435 shares is proposed by PTC Therapeutics (PTCT) officer Mark Boulding. Stock Titan

BestAIBroker analysis

Finance-aware sentiment: slightly negative (-0.10 on a -1 to +1 scale).
Event classification: OTHER.
Market importance score: 27/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
Symbols referenced: PTCT, FACT, PTC, A.